July 20, 2017
Proton beam radiotherapy with concurrent chemoradiotherapy appeared safe and effective among patients with advanced non-small cell lung cancer, according to results of a phase 2 prospective study.
“This is first and only study with 5 years survival of concurrent chemotherapy and proton therapy in inoperable stage III NSCLC,” Joe Y. Chang, MD, PhD, professor of radiation oncology at The University of Texas MD Anderson Cancer Center, told HemOnc Today. “[Proton beam radiotherapy] had a great potential to treat lung cancer. However, the technology is still improving and better result will be achieved in near future.”